SCHEMBL17675351

SCHEMBL17675351

CC(C)=CC(=O)Nc1ccc(I)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.68
▸ NPC1 O15118 3/20 0.68
▸ RAB9A P51151 3/20 0.68
▸ HTT P42858 2/20 0.68
▸ TSHR P16473 1/20 0.68
▸ NFKB1 P19838 1/20 0.68
▸ NFKB2 Q00653 1/20 0.68
▸ RELA Q04206 1/20 0.68
▸ GAA P10253 1/20 0.68
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ TP53 P04637 2/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ SENP8 Q96LD8 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ SENP6 Q9GZR1 1/20 0.51
▸ GPR55 Q9Y2T6 1/20 0.51
▸ PKM P14618 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3713301 0.82 NPC1 (0.70) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL20284039 0.82 NPC1 (0.70) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL5645657 0.81 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL2998577 0.81 SMN1; SMN2 (1.00) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL11759969 0.81 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL4135335 0.81 NPC1 (1.00) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL396577 0.80 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL7679084 0.80 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL7868204 0.78 RAB9A (0.64) SMN1; SMN2NPC1RAB9AHTTTSHR
SCHEMBL2205368 0.78 TGM2 (0.67) SMN1; SMN2NPC1RAB9AHTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3496711-B1 SYNTHETIC RETINOIDS (IN CELL MODULATION) UNIV DURHAM (GB) 2026-03-18 — — EP disclosed
CN-109843291-B Synthetic retinoids (cell modulation) 杜伦大学 2024-06-25 — — CN disclosed
US-11833203-B2 Synthetic retinoids (in cell modulation) UNIVERSITY OF DURHAM 2023-12-05 — — US disclosed
US-11833203-B2 Synthetic retinoids (in cell modulation) UNIVERSITY OF DURHAM 2023-12-05 — — US disclosed
US-11833203-B2 Synthetic retinoids (in cell modulation) UNIVERSITY OF DURHAM 2023-12-05 — — US disclosed
US-11324825-B2 Synthetic retinoids (in cell modulation) UNIVERSITY OF DURHAM 2022-05-10 — — US disclosed
US-11324825-B2 Synthetic retinoids (in cell modulation) UNIVERSITY OF DURHAM 2022-05-10 — — US disclosed
EP-3204357-B1 FLUORESCENT SYNTHETIC RETINOIDS HIGH FORCE RES LIMITED (GB) 2022-01-19 — — EP disclosed
EP-3204357-B1 FLUORESCENT SYNTHETIC RETINOIDS HIGH FORCE RES LIMITED (GB) 2022-01-19 — — EP disclosed
CN-107250112-B Fluorescent synthetic retinoids 高力研究有限公司 2021-04-23 — — CN disclosed
EP-3496711-A1 SYNTHETIC RETINOIDS (IN CELL MODULATION) University Of Durham (GB) 2019-06-19 — — EP disclosed
CN-109843291-A synthetic retinoids (cell modulation) 杜伦大学 2019-06-04 — — CN disclosed
WO-2018029473-A1 SYNTHETIC RETINOIDS (IN CELL MODULATION) UNIVERSITY OF DURHAM (GB) 2018-02-15 — — WO disclosed
WO-2018029473-A1 SYNTHETIC RETINOIDS (IN CELL MODULATION) UNIVERSITY OF DURHAM (GB) 2018-02-15 — — WO disclosed
CN-107250112-A Fluorescence synthesizes retinoid 高力研究有限公司 2017-10-13 — — CN disclosed
EP-3204357-A2 FLUORESCENT SYNTHETIC RETINOIDS High Force Research Limited (GB) 2017-08-16 — — EP disclosed
US-20170217893-A1 Fluorescent Synthetic Retinoids HIGH FORCE RESEARCH LIMITED (GB) 2017-08-03 — — US disclosed
US-20170217893-A1 Fluorescent Synthetic Retinoids HIGH FORCE RESEARCH LIMITED (GB) 2017-08-03 — — US disclosed
US-20170217893-A1 Fluorescent Synthetic Retinoids HIGH FORCE RESEARCH LIMITED (GB) 2017-08-03 — — US disclosed
WO-2016055800-A2 FLUORESCENT SYNTHETIC RETINOIDS HIGH FORCE RESEARCH LIMITED (GB) 2016-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11833203-B2 Synthetic retinoids (in cell modulation) RARA, RARB, RXRA SMN1; SMN2 2432/4885NPC1 1449/4885RAB9A 848/4885
US-11324825-B2 Synthetic retinoids (in cell modulation) RARA, RARB, RXRA SMN1; SMN2 2432/4885NPC1 1449/4885RAB9A 848/4885
US-20170217893-A1 Fluorescent Synthetic Retinoids RARB, RXRB, RXRA SMN1; SMN2 2088/4885NPC1 1401/4885RAB9A 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback